IMNM
Price
$8.77
Change
-$0.02 (-0.23%)
Updated
Jun 27 closing price
Capitalization
763.97M
46 days until earnings call
VTGN
Price
$1.97
Change
-$0.08 (-3.90%)
Updated
Jun 27 closing price
Capitalization
57.44M
Interact to see
Advertisement

IMNM vs VTGN

Header iconIMNM vs VTGN Comparison
Open Charts IMNM vs VTGNBanner chart's image
Immunome
Price$8.77
Change-$0.02 (-0.23%)
Volume$1.07M
Capitalization763.97M
VistaGen Therapeutics
Price$1.97
Change-$0.08 (-3.90%)
Volume$222.36K
Capitalization57.44M
IMNM vs VTGN Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. VTGN commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and VTGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (IMNM: $8.77 vs. VTGN: $1.97)
Brand notoriety: IMNM and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 120% vs. VTGN: 144%
Market capitalization -- IMNM: $763.97M vs. VTGN: $57.44M
IMNM [@Biotechnology] is valued at $763.97M. VTGN’s [@Biotechnology] market capitalization is $57.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than VTGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 4 bearish.
  • VTGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than VTGN.

Price Growth

IMNM (@Biotechnology) experienced а +0.40% price change this week, while VTGN (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($764M) has a higher market cap than VTGN($57.4M). IMNM YTD gains are higher at: -17.420 vs. VTGN (-33.220). VTGN has higher annual earnings (EBITDA): -52.22M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. VTGN (88.6M). VTGN has less debt than IMNM: VTGN (1.71M) vs IMNM (4.77M). IMNM has higher revenues than VTGN: IMNM (10.9M) vs VTGN (698K).
IMNMVTGNIMNM / VTGN
Capitalization764M57.4M1,331%
EBITDA-175.18M-52.22M335%
Gain YTD-17.420-33.22052%
P/E RatioN/AN/A-
Revenue10.9M698K1,562%
Total Cash317M88.6M358%
Total Debt4.77M1.71M278%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SVXYX65.020.42
+0.65%
Smead International Value Y
MRGBX43.220.22
+0.51%
MFS Core Equity B
BMSSX14.520.05
+0.35%
MFS Blended Research Mid Cap Eq R2
EMGEX7.860.01
+0.13%
Emerging Markets Equities Fund F-3
BIGTX15.04-0.06
-0.40%
The Texas I

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.23%
IDYA - IMNM
61%
Loosely correlated
-4.13%
ARWR - IMNM
56%
Loosely correlated
+0.06%
BEAM - IMNM
55%
Loosely correlated
-1.98%
RXRX - IMNM
55%
Loosely correlated
-6.85%
SYRE - IMNM
54%
Loosely correlated
-4.99%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-3.90%
ABOS - VTGN
45%
Loosely correlated
-7.44%
ATAI - VTGN
43%
Loosely correlated
-2.22%
RNA - VTGN
42%
Loosely correlated
-2.68%
IMNM - VTGN
41%
Loosely correlated
-0.23%
IMVT - VTGN
40%
Loosely correlated
-1.77%
More